(Updated at 6:30 p.m. ET)
Medicare considers passing pharmacy rebates to Part D patients
The Trump administration on Monday unveiled another list of proposals to lower drug prices, including a plan to force pharmacies to pass on negotiated price concessions negotiated by pharmacy benefit managers and Medicare Part D plans to the enrollees.
This new policy could start as soon as 2020. It would re-define the "negotiated price," reported by the pharmacy to the CMS as the point-of-sale price for a Part D drug, as the lowest possible payment.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.